AURKA Antibody, Clone: [1364CT291.108.155], Mouse, Monoclonal

Artikelnummer: NSJ-F52530-0.4ML
Artikelname: AURKA Antibody, Clone: [1364CT291.108.155], Mouse, Monoclonal
Artikelnummer: NSJ-F52530-0.4ML
Hersteller Artikelnummer: F52530-0.4ML
Alternativnummer: NSJ-F52530-0.4ML
Hersteller: NSJ Bioreagents
Wirt: Mouse
Kategorie: Antikörper
Applikation: ELISA, IHC, WB
Spezies Reaktivität: Human
Immunogen: This AURKA antibody was produced from a mouse immunized with a KLH conjugated synthetic peptide between amino acids from the human region of human AURKA.
Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizing p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.
Klonalität: Monoclonal
Klon-Bezeichnung: [1364CT291.108.155]
UniProt: O14965
Reinheit: Purified
Formulierung: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Verdünnung: IHC (Paraffin): 1:25,Western blot: 1:1000
Anwendungsbeschreibung: Titration of the AURKA antibody may be required due to differences in protocols and secondary/substrate sensitivity.